Regis Healthcare Future Growth

Future criteria checks 5/6

Regis Healthcare is forecast to grow earnings and revenue by 98.5% and 9.1% per annum respectively. EPS is expected to grow by 96% per annum. Return on equity is forecast to be 184% in 3 years.

Key information

98.5%

Earnings growth rate

96.0%

EPS growth rate

Healthcare earnings growth	19.6%
Revenue growth rate	9.1%
Future return on equity	184.0%
Analyst coverage	Good
Last updated	20 May 2024

Recent future growth updates

Recent updates

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

May 02

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Mar 21

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Feb 28

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 18

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Aug 26

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Feb 25

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

May 27

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

May 09

Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?

Aug 10

At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?

Aug 10

Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years

Jul 14

Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?

Jul 02

Earnings and Revenue Growth Forecasts

ASX:REG - Analysts future estimates and past financials data (AUD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2026	1,162	45	135	158	6
6/30/2025	1,110	43	120	138	6
6/30/2024	1,024	-19	32	165	6
12/31/2023	880	-15	132	195	N/A
9/30/2023	830	-22	93	150	N/A
6/30/2023	781	-28	54	105	N/A
3/31/2023	761	-45	34	78	N/A
12/31/2022	741	-61	14	50	N/A
9/30/2022	733	-50	41	82	N/A
6/30/2022	725	-39	68	115	N/A
3/31/2022	719	-16	N/A	N/A	N/A
12/31/2021	713	8	104	143	N/A
9/30/2021	707	14	96	124	N/A
6/30/2021	701	20	88	105	N/A
3/31/2021	700	8	N/A	N/A	N/A
12/31/2020	699	-4	86	105	N/A
9/30/2020	688	-2	87	116	N/A
6/30/2020	678	-1	88	127	N/A
3/31/2020	655	21	111	156	N/A
12/31/2019	661	39	134	186	N/A
9/30/2019	654	45	144	203	N/A
6/30/2019	647	51	155	220	N/A
3/31/2019	632	51	101	204	N/A
12/31/2018	617	50	47	188	N/A
9/30/2018	606	52	-13	161	N/A
6/30/2018	594	54	-74	134	N/A
3/31/2018	586	56	-74	129	N/A
12/31/2017	577	57	-73	124	N/A
9/30/2017	571	59	N/A	138	N/A
6/30/2017	565	61	N/A	151	N/A
3/31/2017	547	55	N/A	151	N/A
12/31/2016	529	50	N/A	152	N/A
9/30/2016	505	48	N/A	143	N/A
6/30/2016	481	47	N/A	134	N/A
3/31/2016	468	59	N/A	146	N/A
12/31/2015	455	71	N/A	159	N/A
9/30/2015	446	64	N/A	143	N/A
6/30/2015	438	58	N/A	127	N/A
3/31/2015	433	28	N/A	119	N/A
12/31/2014	428	-1	N/A	110	N/A
9/30/2014	419	0	N/A	122	N/A
6/30/2014	410	1	N/A	135	N/A
6/30/2013	354	17	N/A	101	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: REG is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Earnings vs Market: REG is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: REG is expected to become profitable in the next 3 years.

Revenue vs Market: REG's revenue (9.1% per year) is forecast to grow faster than the Australian market (5.4% per year).

High Growth Revenue: REG's revenue (9.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: REG's Return on Equity is forecast to be very high in 3 years time (184%).

Regis Healthcare Future Growth

Future criteria checks 5/6

Key information

Recent future growth updates

Price target increased by 7.3% to AU$3.77

Price target increased by 9.0% to AU$3.52

Price target increased by 7.4% to AU$3.43

Price target increased by 11% to AU$3.07

Price target increased by 7.0% to AU$2.77

Consensus EPS estimates upgraded to AU$0.083 loss

Recent updates

Non-Executive Director recently sold AU$68m worth of stock

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Upcoming dividend of AU$0.063 per share

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

First half dividend increased to AU$0.063

Price target increased by 7.3% to AU$3.77

Price target increased by 9.0% to AU$3.52

Price target increased by 7.4% to AU$3.43

Regis Healthcare Limited to Report First Half, 2024 Results on Feb 26, 2024

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited (ASX:REG) agreed to acquire Cpsm Pty Ltd for AUD 74.2 million.

Price target increased by 11% to AU$3.07

Price target increased by 7.0% to AU$2.77

Consensus EPS estimates upgraded to AU$0.083 loss

Price target increased by 8.7% to AU$2.74

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Price target increased by 8.8% to AU$2.59

Upcoming dividend of AU$0.075 per share at 3.8% yield

Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Consensus EPS estimates fall by 14%, revenue upgraded

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on September 27, 2023

Regis Healthcare Limited Announces the Resignation of Rebecca Dean as Company Secretary

Regis Healthcare Limited, Annual General Meeting, Oct 24, 2023

Regis Healthcare Limited to Report Fiscal Year 2023 Results on Aug 25, 2023

Price target increased by 7.6% to AU$2.33

Consensus EPS estimates fall by 18%

Upcoming dividend of AU$0.02 per share at 3.7% yield

Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

First half 2023 earnings released: AU$0.086 loss per share (vs AU$0.012 loss in 1H 2022)

Regis Healthcare Limited to Report First Half, 2023 Results on Feb 24, 2023

Consensus forecasts updated

Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Upcoming dividend of AU$0.023 per share

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Fiscal Year 2022 Final Dividend, Payable on September 30, 2022

Regis Healthcare Limited, Annual General Meeting, Oct 25, 2022

Consensus forecasts updated

Consensus forecasts updated

Regis Healthcare Limited to Report Fiscal Year 2022 Results on Aug 24, 2022

Now 21% undervalued

Consensus forecasts updated

Upcoming dividend of AU$0.035 per share

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Declares Franked Ordinary Dividend for the Six Months Ended December 31, 2021, Payable on April 8, 2022

Upcoming dividend of AU$0.046 per share

Full year 2021 earnings released

Price target increased to AU$2.49

Consensus forecasts updated

Insufficient new directors

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

Price target increased to AU$2.22

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

Regis Healthcare Limited to Report Fiscal Year 2021 Results on Aug 31, 2021

Regis Healthcare Limited, Annual General Meeting, Oct 26, 2021

Regis Healthcare Limited to Report First Half, 2021 Results on Feb 24, 2021

Washington H. Soul Pattinson and Company Limited and Ashburn Pty Limited cancelled the acquisition of the remaining 72.76% stake in Regis Healthcare Limited (ASX:REG) from Bryan Dorman and others.

Regis Healthcare Limited Declares No Dividend for the Year 2020

New 90-day low: AU$0.98

Regis Healthcare Limited(ASX:REG) dropped from S&P/ASX Small Ordinaries Index

New 90-day low: AU$1.14

Analysts update estimates

Analysts update estimates

New 90-day low - AU$1.25

Price target lowered to AU$1.66